Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer

Urology

Volumn 53, Issue 2, 1999, Pages 302-307

  Miyake, Hideaki ^a   Hara, Isao ^a   Yamanaka, Kazuki ^a   Gohji, Kazuo ^a   Arakawa, Soichi ^a   Kamidono, Sadao ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY PELVIS CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; URETER CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; UROLOGIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032941162     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00486-5     Document Type: Article

References (23)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? N Engl J Med. 285:1990;82-86.
2. Goldfarb M. The fibroblast growth factor family. Cell Growth Differ. 1:1990;439-454.
3. Dvorak H.F., Brown L.F., Detmar M., et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 146:1995;1029-1039.
4. Mizutani Y., Okada Y., Yoshida O. Expression of platelet-derived endothelial cell growth factor in bladder carcinoma. Cancer. 79:1997;1190-1194.
5. Shimoyama S., Gansauge F., Gansauge S., et al. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res. 56:1996;2703-2706.
6. O'Brien T., Cranston D., Fuggle S., et al. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res. 56:1996;2515-2518.
7. Senger D.R., van de Water L., Brown L.F., et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12:1993;303-324.
8. Takano S., Yoshii Y., Kondo S., et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56:1996;2185-2190.
9. Mattern J., Koomagi R., Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br J Cancer. 73:1996;931-934.
10. Brown L.F., Berse B., Jackman R.W., et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol. 26:1995;86-91.
11. O'Brien T., Cranston D., Fuggle S., et al. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 55:1995;510-513.
12. Zhang H.T., Craft P., Scott P.A., et al. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst. 87:1995;213-219.
13. Claffey K.P., Brown L.F., Aguila L., et al. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 56:1996;172-181.
14. Dickson A., Fox S., Persad R., et al. Quantitation of angiogenesis is an independent predictor of prognosis in invasive bladder cancer. Br J Urol. 74:1994;762-766.
15. Chopin D.K., Caruelle J.P., Colombel M., et al. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J Urol. 150:1993;1126-1130.
16. Nguyen M., Watanabe H., Budson A., et al. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst. 85:1993;241-242.
17. Miyake H., Hara I., Fujisawa M., et al. Prognostic significance in patients with upper urinary tract cancers. Int J Clin Oncol. 1:1996;135-138.
18. Miyake H., Yoshimura K., Hara I., et al. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. J Urol. 157:1997;2351-2355.
19. Salven P., Maenpaa H., Orpana A., et al. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res. 3:1997;647-651.
20. Yamamoto S., Konishi I., Mandai M., et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms correlation with clinicopathoogy and patient survival, and analysis of serum VEGF levels . Br J Cancer. 76:1997;1221-1227.
21. Freeman M.R., Schneck F.X., Gagnon M.L., et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor a potential role for T cells in angiogenesis . Cancer Res. 55:1995;4140-4145.
22. Berse B., Brown L.F., van de Water L., et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 3:1992;211-215.
23. Raghavan D., Shipley W., Garnick M., et al. The biology and management of bladder cancer. N Engl J Med. 322:1990;1129-1138.